Home › Funds › GW&K Investment Management, LLC › GMED

GW&K Investment Management, LLC position in GMED

GLOBUS MED INC · Health Care

GW&K Investment Management, LLC reported holding 1,472,542 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$110.3M, representing 0.93% of its reported portfolio and ranking #10 among its reported holdings. GW&K Investment Management, LLC has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.47M sh
Reported value held$110.29M
Portfolio Weight0.93%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GW&K Investment Management, LLC's GMED position evolved

GW&K Investment Management, LLC first disclosed a stake in GMED in Q3 2023 at 1,663,270 shares (US$82.6M). The position peaked in Q4 2024 at 1,745,115 shares, worth US$144.3M. Across 13 filings, GW&K Investment Management, LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,472,542 shares valued at US$110.3M — an increase of 19,336 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.66M $82.58M New
Q4 2023 1.76M $93.79M Add
Q1 2024 1.75M $93.69M Reduce
Q2 2024 1.76M $120.54M Add
Q3 2024 1.75M $125.38M Hold
Q4 2024 1.75M $144.34M Hold
Q1 2025 1.72M $125.90M Reduce
Q2 2025 1.85M $109.17M Add
Q3 2025 1.78M $101.79M Reduce
Q4 2025 1.52M $132.39M Reduce
Q1 2026 1.49M $128.79M Reduce
Q2 2026 1.45M $114.82M Reduce
Q3 2026 1.47M $110.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 35 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has GW&K Investment Management, LLC held GMED?

GW&K Investment Management, LLC has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GW&K Investment Management, LLC's current position in GMED?

As of Q3 2026, GW&K Investment Management, LLC holds 1.47M shares of GMED (GLOBUS MED INC), valued at $110.29M, representing 0.93% of its reported portfolio and ranking #10.

Has GW&K Investment Management, LLC been buying or selling GMED?

In the latest 13F filing (Q3 2026), GW&K Investment Management, LLC increased its position in GMED. The position peaked in Q4 2024 at 1.75M shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.